Dr. Pikman on Matching Pediatric Patients With More Precise Leukemia Therapy

Yana Pikman, MD
Published: Thursday, Dec 27, 2018



Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses a trial attempting to match pediatric patients with more precise therapy for acute leukemia. Early findings were reported at the 2018 ASH Annual Meeting.

At the time of enrollment, pediatric patients had a sample of their leukemia sequenced and those data were reviewed by a panel of pediatric oncologists, therapeutic experts, and pathologists. Pikman says this process was to determine if researchers were able to identify any targetable mutations. If a targetable recommendation was made, the information was passed along to try to match a corresponding therapy.

This was a feasibility study, and Pikman says the next steps would include therapeutic studies testing the efficacy of the targeted agents. Researchers are discovering a number of novel genomic findings and identifying their significance to see whether therapy can be tailored towards them.
SELECTED
LANGUAGE


Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses a trial attempting to match pediatric patients with more precise therapy for acute leukemia. Early findings were reported at the 2018 ASH Annual Meeting.

At the time of enrollment, pediatric patients had a sample of their leukemia sequenced and those data were reviewed by a panel of pediatric oncologists, therapeutic experts, and pathologists. Pikman says this process was to determine if researchers were able to identify any targetable mutations. If a targetable recommendation was made, the information was passed along to try to match a corresponding therapy.

This was a feasibility study, and Pikman says the next steps would include therapeutic studies testing the efficacy of the targeted agents. Researchers are discovering a number of novel genomic findings and identifying their significance to see whether therapy can be tailored towards them.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Acute Myeloid LeukemiaMar 30, 20190.75
AML Year in Review™: Live Webcast Around the WorldApr 16, 20192.0
Publication Bottom Border
Border Publication
x